Elkridge, Maryland–(Newsfile Corp. – October 8, 2024)
Vici Health Sciences, a leading provider of pharmaceutical formulation, analytical, and regulatory services, is pleased to announce a significant expansion of its staff and physical footprint in Maryland. The expansion is in response to increasing demand for the company’s comprehensive pharmaceutical development services, enabling Vici Health Sciences to better serve its growing client base.
Dr Anish Dhanarajan, CEO and co-founder stated: “We work hard to provide our clients innovative R&D solutions to bring their drugs to the market. Our clients want to develop high quality pharmaceutical drug products rapidly and clearly recognize the value we are able to provide. This expansion will allow us to meet the growing demand for our services.”
